Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration (International Journal of Clinical Oncology, (2019), 24, 5, (546-553), 10.1007/s10147-018-01388-5)

Keisuke Shigeta, Takeo Kosaka, Hiroshi Hongo, Yoshinori Yanai, Kazuhiro Matsumoto, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Mototsugu Oya

研究成果: Comment/debate査読

抄録

In the Original Publication, Tables 2 and 3 have been published with “###” instead of numerical values. Also in Table 2, few entries were inadvertently published in bold. The corrected tables are given in this Correction. The errors have been occurred at Publisher’s end. The original article has been corrected.

本文言語English
ページ(範囲)554-556
ページ数3
ジャーナルInternational Journal of Clinical Oncology
24
5
DOI
出版ステータスPublished - 2019 5 15

ASJC Scopus subject areas

  • 外科
  • 血液学
  • 腫瘍学

フィンガープリント

「Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration (International Journal of Clinical Oncology, (2019), 24, 5, (546-553), 10.1007/s10147-018-01388-5)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル